BACKGROUND: Increased secretion of growth hormone leads to gigantism in children and acromegaly in adults; the genetic causes of gigantism and acromegaly are poorly understood. METHODS: We performed clinical and genetic studies of samples obtained from 43 patients with gigantism and then sequenced an implicated gene in samples from 248 patients with acromegaly. RESULTS: We observed microduplication on chromosome Xq26.3 in samples from 13 patients with gigantism; of these samples, 4 were obtained from members of two unrelated kindreds, and 9 were from patients with sporadic cases. All the patients had disease onset during early childhood. Of the patients with gigantism who did not carry an Xq26.3 microduplication, none presented before the age of 5 years. Genomic characterization of the Xq26.3 region suggests that the microduplications are generated during chromosome replication and that they contain four protein-coding genes. Only one of these genes, GPR101, which encodes a G-protein-coupled receptor, was overexpressed in patients' pituitary lesions. We identified a recurrent GPR101 mutation (p.E308D) in 11 of 248 patients with acromegaly, with the mutation found mostly in tumors. When the mutation was transfected into rat GH3 cells, it led to increased release of growth hormone and proliferation of growth hormone-producing cells. CONCLUSIONS: We describe a pediatric disorder (which we have termed X-linked acrogigantism [X-LAG]) that is caused by an Xq26.3 genomic duplication and is characterized by early-onset gigantism resulting from an excess of growth hormone. Duplication of GPR101 probably causes X-LAG. We also found a recurrent mutation in GPR101 in some adults with acromegaly. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.).
BACKGROUND: Increased secretion of growth hormone leads to gigantism in children and acromegaly in adults; the genetic causes of gigantism and acromegaly are poorly understood. METHODS: We performed clinical and genetic studies of samples obtained from 43 patients with gigantism and then sequenced an implicated gene in samples from 248 patients with acromegaly. RESULTS: We observed microduplication on chromosome Xq26.3 in samples from 13 patients with gigantism; of these samples, 4 were obtained from members of two unrelated kindreds, and 9 were from patients with sporadic cases. All the patients had disease onset during early childhood. Of the patients with gigantism who did not carry an Xq26.3 microduplication, none presented before the age of 5 years. Genomic characterization of the Xq26.3 region suggests that the microduplications are generated during chromosome replication and that they contain four protein-coding genes. Only one of these genes, GPR101, which encodes a G-protein-coupled receptor, was overexpressed in patients' pituitary lesions. We identified a recurrent GPR101 mutation (p.E308D) in 11 of 248 patients with acromegaly, with the mutation found mostly in tumors. When the mutation was transfected into rat GH3 cells, it led to increased release of growth hormone and proliferation of growth hormone-producing cells. CONCLUSIONS: We describe a pediatric disorder (which we have termed X-linked acrogigantism [X-LAG]) that is caused by an Xq26.3 genomic duplication and is characterized by early-onset gigantism resulting from an excess of growth hormone. Duplication of GPR101 probably causes X-LAG. We also found a recurrent mutation in GPR101 in some adults with acromegaly. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.).
Authors: A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers Journal: J Clin Endocrinol Metab Date: 2006-06-20 Impact factor: 5.958
Authors: R S Møller; L R Jensen; S M Maas; J Filmus; M Capurro; C Hansen; C L M Marcelis; K Ravn; J Andrieux; M Mathieu; M Kirchhoff; O K Rødningen; N de Leeuw; H G Yntema; G Froyen; J Vandewalle; K Ballon; E Klopocki; S Joss; J Tolmie; A C Knegt; A M Lund; H Hjalgrim; A W Kuss; N Tommerup; R Ullmann; A P M de Brouwer; P Strømme; S Kjaergaard; Z Tümer; T Kleefstra Journal: Hum Genet Date: 2013-12-11 Impact factor: 4.132
Authors: F Gurrieri; M G Pomponi; R Pietrobono; E Lucci-Cordisco; E Silvestri; G Storniello; G Neri Journal: Am J Med Genet A Date: 2010-12-09 Impact factor: 2.802
Authors: Paweł Stankiewicz; Hannelore Thiele; Mike Schlicker; Andrea Cseke-Friedrich; Sylva Bartel-Friedrich; Svetlana A Yatsenko; James R Lupski; Ingo Hansmann Journal: Am J Med Genet A Date: 2005-09-15 Impact factor: 2.802
Authors: Sven Gläsker; Alexander O Vortmeyer; Antony R A Lafferty; Paul L Hofman; Jie Li; Robert J Weil; Zhengping Zhuang; Edward H Oldfield Journal: J Clin Endocrinol Metab Date: 2011-10-05 Impact factor: 5.958
Authors: S Bergamaschi; C L Ronchi; C Giavoli; E Ferrante; E Verrua; D I Ferrari; A Lania; R Rusconi; A Spada; P Beck-Peccoz Journal: Horm Res Paediatr Date: 2010-01-15 Impact factor: 2.852
Authors: Feng Zhang; Mehrdad Khajavi; Anne M Connolly; Charles F Towne; Sat Dev Batish; James R Lupski Journal: Nat Genet Date: 2009-06-21 Impact factor: 38.330
Authors: Alexander H Li; Neil A Hanchard; Mahshid Azamian; Lisa C A D'Alessandro; Zeynep Coban-Akdemir; Keila N Lopez; Nancy J Hall; Heather Dickerson; Annarita Nicosia; Susan Fernbach; Philip M Boone; Tomaz Gambin; Ender Karaca; Shen Gu; Bo Yuan; Shalini N Jhangiani; HarshaVardhan Doddapaneni; Jianhong Hu; Huyen Dinh; Joy Jayaseelan; Donna Muzny; Seema Lalani; Jeffrey Towbin; Daniel Penny; Charles Fraser; James Martin; James R Lupski; Richard A Gibbs; Eric Boerwinkle; Stephanie M Ware; John W Belmont Journal: Eur J Hum Genet Date: 2019-01-08 Impact factor: 4.246
Authors: Jill Samis; Elio F Vanin; Simone Treiger Sredni; Maria de Fátima de Bonaldo; Fabricio F Costa; Tadanori Tomita; Reema Habiby; Donald Zimmerman; Marcelo B Soares Journal: Childs Nerv Syst Date: 2016-06-07 Impact factor: 1.475
Authors: Sosipatros A Boikos; Paraskevi Xekouki; Elena Fumagalli; Fabio R Faucz; Margarita Raygada; Eva Szarek; Evan Ball; Su Young Kim; Markku Miettinen; Lee J Helman; J Aidan Carney; Karel Pacak; Constantine A Stratakis Journal: Eur J Hum Genet Date: 2015-07-15 Impact factor: 4.246
Authors: Paraskevi Xekouki; Ana Brennand; Ben Whitelaw; Karel Pacak; Constantine A Stratakis Journal: Horm Metab Res Date: 2018-10-01 Impact factor: 2.936
Authors: Elisabeth M Lodder; Pasquelena De Nittis; Charlotte D Koopman; Wojciech Wiszniewski; Carolina Fischinger Moura de Souza; Najim Lahrouchi; Nicolas Guex; Valerio Napolioni; Federico Tessadori; Leander Beekman; Eline A Nannenberg; Lamiae Boualla; Nico A Blom; Wim de Graaff; Maarten Kamermans; Dario Cocciadiferro; Natascia Malerba; Barbara Mandriani; Zeynep Hande Coban Akdemir; Richard J Fish; Mohammad K Eldomery; Ilham Ratbi; Arthur A M Wilde; Teun de Boer; William F Simonds; Marguerite Neerman-Arbez; V Reid Sutton; Fernando Kok; James R Lupski; Alexandre Reymond; Connie R Bezzina; Jeroen Bakkers; Giuseppe Merla Journal: Am J Hum Genet Date: 2016-08-11 Impact factor: 11.025